Richard G Moore

12PUBLICATIONS
96CO-AUTHORS
Nanoscale characterisationCancer therapy (excl. chemotherapy and radiation therapy)Horticultural crop improvement (incl. selection and breeding)Predictive and prognostic markersMolecular medicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Jun 22, 2026
Reconstruction of septin higher-order nano-size structures in ovarian cancer cells uncover susceptibility to the septin-targeting small molecule UR214-9.

|Nov 26, 2024
First-Line Lenvatinib Plus Pembrolizumab Versus Chemotherapy for Advanced Endometrial Cancer: A Randomized, Open-Label, Phase III Trial.

Christian Marth, Richard G Moore, Mariusz Bidziński

|Oct 03, 2024
Cediranib and Olaparib Combination Compared With Cediranib or Olaparib Alone, or Chemotherapy in Platinum-Resistant or Primary Platinum-Refractory Ovarian Cancer: NRG-GY005.

Jung-Min Lee, Mark F Brady, Austin Miller

|Mar 13, 2024
Forchlorfenuron-Induced Mitochondrial Respiration Inhibition and Metabolic Shifts in Endometrial Cancer.

Kyukwang Kim, Negar Khazan, Rachael B Rowswell-Turner

|Jan 09, 2024
Normal Risk Ovarian Screening Study: 21-Year Update.

Chae Young Han, Karen H Lu, Gwen Corrigan

|Jul 14, 2023
Vitamin D Receptor Antagonist MeTC7 Inhibits PD-L1.

Negar Khazan, Emily R Quarato, Niloy A Singh

Pageof 2

Frequent Collaborators

4 joint publications

Rakesh K Singh

2 joint publications

Cameron W A Snyder

2 joint publications

Naohiro Yano

2 joint publications

Stephanie Lheureux